This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Frank B. Vasey, MD; Luis R. Espinoza, MD; Pindaro Martinez-Osuna, MD; Mitchel J. Seleznick, MD; Stephen J. Brozena, MD; Neil A. Penske, MD
Division of Rheumatology; Division of General Internal Medicine and Rheumatology; Division of Dermatology and Cutaneous Surgery University of South Florida College of Medicine 12901 Bruce B. Downs Blvd (Box 19) Tampa, FL 33612-4799

Arch Dermatol. 1991;127(6):907.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We read with interest the recent article by Sahn et al.¹ In addition to the two referenced patients we reported in 1988,² we have now seen more than 20 women with muscle pain, joint pain, and swelling, pulmonary disease including pleural effusion³ infiltrates and reduced carbon monoxide diffusing capacity, dry eyes and mouth, dysphagia, bladder dysfunction, neurological disease, and skin disease including localized and diffuse sclerodermalike changes.

We agree that rupture of a gel-filled prosthesis is the most likely event before systemic symptoms. In some of our patients the gel-filled prosthesis was intact, but amorphous material characteristic of silicon was identified by light microscopy in the surgically removed fibrous capsules. Two of our patients with muscle pain, joint pain, and swelling had only saline-filled silicon implants. In the one patient whose fibrous capsules were removed with the prosthesis, amorphous material compatible with silicon was . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?